[PBBANK] QoQ Annualized Quarter Result on 30-Jun-2023 [#2]

Announcement Date
29-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- -2.78%
YoY- 18.36%
View:
Show?
Annualized Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 27,178,892 25,415,010 25,156,065 24,773,062 24,492,948 21,426,926 20,485,354 20.72%
PBT 8,526,828 8,538,788 8,628,217 8,608,902 8,835,932 8,831,050 8,413,477 0.89%
Tax -1,898,316 -1,883,775 -1,884,308 -1,907,264 -1,943,912 -2,661,423 -2,481,989 -16.35%
NP 6,628,512 6,655,013 6,743,909 6,701,638 6,892,020 6,169,627 5,931,488 7.68%
-
NP to SH 6,613,396 6,649,314 6,711,809 6,665,076 6,855,852 6,119,499 5,874,429 8.21%
-
Tax Rate 22.26% 22.06% 21.84% 22.15% 22.00% 30.14% 29.50% -
Total Cost 20,550,380 18,759,997 18,412,156 18,071,424 17,600,928 15,257,299 14,553,866 25.83%
-
Net Worth 54,586,748 54,674,095 53,210,531 53,303,699 51,308,282 50,178,577 49,213,866 7.14%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div - 3,688,031 2,329,283 3,493,924 - 3,299,817 3,105,710 -
Div Payout % - 55.46% 34.70% 52.42% - 53.92% 52.87% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 54,586,748 54,674,095 53,210,531 53,303,699 51,308,282 50,178,577 49,213,866 7.14%
NOSH 19,410,691 19,410,691 19,410,691 19,410,691 19,410,691 19,410,691 19,410,691 0.00%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 24.39% 26.19% 26.81% 27.05% 28.14% 28.79% 28.95% -
ROE 12.12% 12.16% 12.61% 12.50% 13.36% 12.20% 11.94% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 140.02 130.93 129.60 127.63 126.18 110.39 105.54 20.71%
EPS 34.08 34.26 34.57 34.34 35.32 31.53 30.27 8.21%
DPS 0.00 19.00 12.00 18.00 0.00 17.00 16.00 -
NAPS 2.8122 2.8167 2.7413 2.7461 2.6433 2.5851 2.5354 7.14%
Adjusted Per Share Value based on latest NOSH - 19,410,691
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 140.02 130.93 129.60 127.63 126.18 110.39 105.54 20.71%
EPS 34.08 34.26 34.57 34.34 35.32 31.53 30.27 8.21%
DPS 0.00 19.00 12.00 18.00 0.00 17.00 16.00 -
NAPS 2.8122 2.8167 2.7413 2.7461 2.6433 2.5851 2.5354 7.14%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 4.22 4.29 4.06 3.85 4.00 4.32 4.23 -
P/RPS 3.01 3.28 3.13 3.02 3.17 3.91 4.01 -17.39%
P/EPS 12.39 12.52 11.74 11.21 11.33 13.70 13.98 -7.72%
EY 8.07 7.99 8.52 8.92 8.83 7.30 7.15 8.39%
DY 0.00 4.43 2.96 4.68 0.00 3.94 3.78 -
P/NAPS 1.50 1.52 1.48 1.40 1.51 1.67 1.67 -6.90%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 20/05/24 28/02/24 29/11/23 29/08/23 25/05/23 27/02/23 30/11/22 -
Price 4.19 4.43 4.24 4.12 3.89 4.15 4.50 -
P/RPS 2.99 3.38 3.27 3.23 3.08 3.76 4.26 -21.00%
P/EPS 12.30 12.93 12.26 12.00 11.01 13.16 14.87 -11.87%
EY 8.13 7.73 8.16 8.33 9.08 7.60 6.73 13.41%
DY 0.00 4.29 2.83 4.37 0.00 4.10 3.56 -
P/NAPS 1.49 1.57 1.55 1.50 1.47 1.61 1.77 -10.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment